国内厄达替尼2021年5月价格多少？国内哪能买到厄达替尼？

Erdafitinib (Balversa) is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma who (1) have predisposing FGFR3 or FGFR2 genetic alterations; and (2) received during or after at least one prior line of platinum-containing chemotherapy, including neoadjuvant platinum-containing chemotherapy within 12 days. As early as 2005, the American pharmaceutical company Astex had collaborated with the UK Cancer Research Drug Discovery Group and Cancer Research Technologies Ltd. at the University of Newcastle (Newcastle) in the UK to start a research plan for FGFR inhibitors. In March 2018, the U.S. Food and Drug Administration (FDA) granted (Balversa) Breakthrough Therapy Designation for the treatment of urothelial cancer. How much does the kinase inhibitor erdafitinib (Balversa) cost? Where can I buy this medicine? 

What is the domestic price of erdafitinib in May 2021? Where can I buy Erdafitinib in China?

It is understood that Erdafitinib has not been officially launched in mainland China, so patients cannot purchase the drug in mainland China. Erdafitinib exported to Hong Kong by Janssen is 4mg*28 tablets with a price of about $106,500. Patients who purchase Erdafitinib exported to Hong Kong by Janssen need to purchase it through formal channels. One is to go to Hong Kong to buy it in person, ask a hospital doctor to write a prescription, and then take the medicine back to China for treatment. The second is to find domestic overseas medical service institutions (such as Medical Companion Travel), and let them translate the cases, express the medicines to the patients by direct mail, and also provide guidance and answer questions for the patients during the medication. This is currently the most economical and feasible solution.

Erdafitinib (Balversa) usage and dosage

Recommended dose of erdafitinib (Balversa): The starting dose is 8 mg once daily, taken orally on an empty stomach or with food. For patients whose serum phosphorus levels fall below the target value of 5.5 mg/dL between days 14 and 21, the dose is increased to 9 mg once daily until disease progression or intolerance. If vomiting occurs after taking the medicine, do not take additional doses of Erdafitinib (Balversa), and the next dose should still be taken at the original interval. If you miss a dose, you can take it again according to the amount within the same day, and the next time you take the medicine, you should still follow the original interval.

The above is an introduction to the price and purchase channels of Erdafitinib (Balversa). I hope it can help everyone.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician. 

Recommended hot articles